论文标题
立体定向放射外科手术的新旋转伽马系统的剂量评估
Dosimetric Evaluation of a New Rotating Gamma System for Stereotactic Radiosurgery
论文作者
论文摘要
目的:一种具有实时图像指导技术的新型旋转伽玛立体定向放射外科(SRS)系统(Galaxy RTI)已为高精度SRS和无框架分级的立体定向放射疗法(SRT)开发。这项工作通过比较机器处理参数和计划剂量测定参数与SRS广泛使用的Leksell Gamma刀(LGK)系统的剂量剂量进行了研究。方法:Galaxy RTI系统在旋转龙门上使用30个钴-60来源,同时提供非稳定的非重叠弧,而LGK 4C使用201静态钴-60来源来提供非稳态光束。从我们的临床数据库中,十名脑癌患者未经构建,该数据库以前在LGK 4C上进行过治疗。这些情况的病变体积从0.1 cm3到15.4 cm3不等。使用具有相同剂量约束和优化参数的能力TPS(Prowess,Concord,CA)生成星系计划。将治疗质量指标(例如目标覆盖率(接受处方剂量的%),合格指数(CI),圆锥大小,镜头数,光束时间与DVH曲线和剂量分布进行比较。结果:为符合我们临床接受标准的星系系统制定了卓越的治疗计划。对于研究的10名患者,星系的平均CI和剂量覆盖率分别为1.77和99.24,而LGK分别为1.94和99.19。银河系的光束时间为17.42分钟,而LGK为21.34分钟(都假设在初始安装时剂量率)。与LGK相比,银河系的剂量下降要快得多。结论:Galaxy RTI系统可以提供与LGK质量相似的剂量分布,而LGK的时间较小,剂量降低了。该系统还能够在治疗位置进行实时图像指导,以确保SRS的准确剂量递送。
Purpose: A novel rotating gamma stereotactic radiosurgery (SRS) system (Galaxy RTi) with real-time image guidance technology has been developed for high-precision SRS and frameless fractionated stereotactic radiotherapy (SRT). This work investigated the dosimetric quality of Galaxy by comparing both the machine treatment parameters and plan dosimetry parameters with those of the widely used Leksell Gamma Knife (LGK) systems for SRS. Methods: The Galaxy RTi system uses 30 cobalt-60 sources on a rotating gantry to deliver non-coplanar, non-overlapping arcs simultaneously while the LGK 4C uses 201 static cobalt-60 sources to deliver noncoplanar beams. Ten brain cancer patients were unarchived from our clinical database, which were previously treated on the LGK 4C. The lesion volume for these cases varied from 0.1 cm3 to 15.4 cm3. Galaxy plans were generated using the Prowess TPS (Prowess, Concord, CA) with the same dose constraints and optimization parameters. Treatment quality metrics such as target coverage (%volume receiving the prescription dose), conformity index (CI), cone size, shots number, beam-on time were compared together with DVH curves and dose distributions. Results: Superior treatment plans were generated for the Galaxy system that met our clinical acceptance criteria. For the 10 patients investigated, the mean CI and dose coverage for Galaxy was 1.77 and 99.24 compared to 1.94 and 99.19 for LGK, respectively. The beam-on time for Galaxy was 17.42 minutes compared to 21.34 minutes for LGK (both assuming dose rates at the initial installation). The dose fall-off is much faster for Galaxy, compared with LGK. Conclusion: The Galaxy RTi system can provide dose distributions with similar quality to that of LGK with less beam-on time and faster dose fall-off. The system is also capable of real-time image guidance at treatment position to ensure accurate dose delivery for SRS.